Ventures West contributes a wealth of resources to each of its venture capital investees.
With 5 professional technology investment managers, and one of the most productive Entrepreneur-In-Residence programs in Canada, the Ventures West team has over 100 years of technology venture investing and hands-on operating experience.
Ventures West has a unique set of capabilities - a long and successful track record in venture capital investing, management depth, extensive contacts in North American technology, financial, and venture capital industries, and the ability to form investor syndicates.
July 15, 2010
MacroGenics Receives NIH Grant Funding of $9.8M for Three Projects; Funding Further Advances DART Platform and Infectious Disease Portfolio
July 14, 2010
Presidio Pharmaceuticals, Inc. Successfully Completes Phase 1a Clinical Trial of PPI-461, a Potent, New Hepatitis C Virus (HCV) Inhibitor
June 21, 2010
Celator Pharmaceuticals Expands Research Agreement With Cephalon
June 17, 2010
Aquinox Pharmaceuticals Completes US $25 Million Series B Financing
